In vitro experiments have shown that applying exogenous ghrelin to gastric cancer cells increases COX-2 expression via the PI3K/Akt pathway, thereby inhibiting apoptosis and promoting proliferation and metastasis [94]. This evidence concerns the gene GHRL and gastric cancer.